233 related articles for article (PubMed ID: 22937210)
1. ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW.
Zhang Y; Hong H; Severin GW; Engle JW; Yang Y; Goel S; Nathanson AJ; Liu G; Nickles RJ; Leigh BR; Barnhart TE; Cai W
Am J Transl Res; 2012; 4(3):333-46. PubMed ID: 22937210
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105.
Hong H; Severin GW; Yang Y; Engle JW; Zhang Y; Barnhart TE; Liu G; Leigh BR; Nickles RJ; Cai W
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):138-48. PubMed ID: 21909753
[TBL] [Abstract][Full Text] [Related]
3. In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis.
Yang Y; Zhang Y; Hong H; Liu G; Leigh BR; Cai W
Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2066-76. PubMed ID: 21814852
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody.
Zhang Y; Hong H; Engle JW; Yang Y; Theuer CP; Barnhart TE; Cai W
Mol Pharm; 2012 Mar; 9(3):645-53. PubMed ID: 22292418
[TBL] [Abstract][Full Text] [Related]
5. WE-C-217BCD-04: Multimodality Imaging of Breast Cancer Experimental Lung Metastasis.
Zhang Y; Hong H; Yang Y; Severin G; Engle J; Niu G; Chen X; Leigh B; Barnhart T; Cai W
Med Phys; 2012 Jun; 39(6Part27):3950. PubMed ID: 28519986
[TBL] [Abstract][Full Text] [Related]
6. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W
Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463
[TBL] [Abstract][Full Text] [Related]
7. Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW.
Hong H; Zhang Y; Severin GW; Yang Y; Engle JW; Niu G; Nickles RJ; Chen X; Leigh BR; Barnhart TE; Cai W
Mol Pharm; 2012 Aug; 9(8):2339-49. PubMed ID: 22784250
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography imaging of CD105 expression during tumor angiogenesis.
Hong H; Yang Y; Zhang Y; Engle JW; Barnhart TE; Nickles RJ; Leigh BR; Cai W
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1335-43. PubMed ID: 21373764
[TBL] [Abstract][Full Text] [Related]
9. Dual-labeled pertuzumab for multimodality image-guided ovarian tumor resection.
Lee HJ; Ehlerding EB; Jiang D; Barnhart TE; Cao T; Wei W; Ferreira CA; Huang P; Engle JW; Cai W
Am J Cancer Res; 2019; 9(7):1454-1468. PubMed ID: 31392081
[TBL] [Abstract][Full Text] [Related]
10. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragment.
Zhang Y; Hong H; Orbay H; Valdovinos HF; Nayak TR; Theuer CP; Barnhart TE; Cai W
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):759-67. PubMed ID: 23344138
[TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab.
Zhang Y; Hong H; Engle JW; Yang Y; Barnhart TE; Cai W
Am J Nucl Med Mol Imaging; 2012 Jan; 2(1):1-13. PubMed ID: 22229128
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
